Details for New Drug Application (NDA): 075710
✉ Email this page to a colleague
The generic ingredient in ALENDRONATE SODIUM is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for 075710
Tradename: | ALENDRONATE SODIUM |
Applicant: | Impax Labs Inc |
Ingredient: | alendronate sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 075710
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 075710 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-1676 | 0115-1676-01 | 100 TABLET in 1 BOTTLE (0115-1676-01) |
ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 075710 | ANDA | Amneal Pharmaceuticals of New York LLC | 0115-1676 | 0115-1676-08 | 30 TABLET in 1 BOTTLE (0115-1676-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Feb 6, 2008 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Feb 6, 2008 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 35MG BASE | ||||
Approval Date: | Feb 6, 2008 | TE: | RLD: | No |
Complete Access Available with Subscription